Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Omnicyte Logo
Omnicyte Growth Score
36
CB Rank
153772
Heat Score
69
Omnicyte is a biotechnology company that develops targeted treatments for cancer therapy.
Founded
obfuscation
PrivateGrant Branford, Connecticut, United States1-10 www.omnicyte.com
Biotechnology
Health Care
Product Research
Overview

Omnicyte
Total Funding
obfuscation
Growth Score
36
Heat Score
69

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score36
-1 pts
in past quarter
Heat Score 69
-8 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Omnicyte

CB Rank
153772
Omnicyte is a biotechnology company that develops targeted treatments for cancer therapy.
Founded
obfuscation
PrivateGrant Branford, Connecticut, United States1-10 www.omnicyte.com
Biotechnology
Health Care
Product Research

Funding Rounds

Grant
OBF
in
obfuscation
Convertible Note
OBF
in
obfuscation

Key People

Details

Legal Name OmniCyte LLC
Operating Status Active
Company Type For Profit
Founders  Angel Pellicer, Peter Leonardi
About the Company
Omnicyte is a biotechnology company that develops targeted treatments for cancer therapy. The company develops a proprietary Immuno-Oncology Platform Technology for recombinant targeted immunomodulators, ovarian cancer indication, small cell lung cancer, and multiple additional indications.
Phone Number 1 (917) 439-7479
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Targeted Immuno-oncology Therapeutic, Program I
A biologic therapeutic using a bi-specific multimeric viral glycoprotein and tumor-associated antigen complex to activate immune cells against specific tumor types.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Omnicyte Logo
Grant - Omnicyte
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Omnicyte Logo
Grant - Omnicyte
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Omnicyte Logo
Grant - Omnicyte
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Omnicyte Logo
Grant - Omnicyte
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Omnicyte Logo
Grant - Omnicyte
1
obfuscation
National Science FoundationGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Omnicyte Logo
Grant - Omnicyte
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Omnicyte Logo
Grant - Omnicyte
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Omnicyte Logo
Grant - Omnicyte
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Omnicyte Logo
Grant - Omnicyte
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Omnicyte Logo
Grant - Omnicyte
1
obfuscation
National Science FoundationGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
National Science Foundation Logo
National Science Foundation
Yes
Grant - Omnicyte Logo
Grant - Omnicyte
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - Omnicyte Logo
Grant - Omnicyte
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - Omnicyte Logo
Grant - Omnicyte
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - Omnicyte Logo
Grant - Omnicyte
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - Omnicyte Logo
Grant - Omnicyte
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2

Employee Profiles

News
Technology
View Tech Report

IT Spend

$45.6KThis year, Omnicyte is projected to spend $45.6K on IT, according to Aberdeen.

Active Website Tech Count

4Omnicyte is actively using 4 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Pound Sterling.
Sub-Organizations
Frequently Asked Questions

Where is Omnicyte's headquarters? Omnicyte is located in Branford, Connecticut, United States.Who invested in Omnicyte? Omnicyte has 2 investors including National Science Foundation and  Connecticut Innovations.When was the last funding round for Omnicyte? Omnicyte closed its last funding round on
obfuscation
from a Grant round.Who are Omnicyte's competitors? Alternatives and possible competitors to Omnicyte may include ImmunityBio, Genelux, and  Replimune Group.How much funding has Omnicyte raised to date? Omnicyte has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|